Mutations in RARS Cause Hypomyelination

N.I. Wolf, G.S. Salomons, R.J. Rodenburg, P.J.W. Pouwels, J.H. Schieving, T.G.J. Derks, J.M. Fock, P. Rump, D.M. van Beek, M.S. van der Knaap, Q. Waisfisz

    Research output: Contribution to JournalArticleAcademicpeer-review

    Abstract

    Hypomyelinating disorders of the central nervous system are still a diagnostic challenge, as many patients remain without genetic diagnosis. Using magnetic resonance imaging (MRI) pattern recognition and whole exome sequencing, we could ascertain compound heterozygous mutations in RARS in 4 patients with hypomyelination. Clinical features included severe spasticity and nystagmus. RARS encodes the cytoplasmic arginyl-tRNA synthetase, an enzyme essential for RNA translation. This protein is among the subunits of the multisynthetase complex, which emerges as a key player in myelination. Ann Neurol 2014;76:134-139 © 2014 American Neurological Association.
    Original languageEnglish
    Pages (from-to)134-139
    JournalAnnals of Neurology
    Volume76
    Issue number1
    DOIs
    Publication statusPublished - 2014

    Fingerprint

    Dive into the research topics of 'Mutations in RARS Cause Hypomyelination'. Together they form a unique fingerprint.

    Cite this